至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Rapid and Sensitive Detection of COVID-19 Using CRISPR/Cas12a-based Detection With Naked Eye Readout, CRISPR/Cas12a-NER

Sci Bull (Beijing). 2020-04; 
Xinjie Wang , Mingtian Zhong , Yong Liu , Peixiang Ma , Lu Dang , Qingzhou Meng , Wenwei Wan , Xiaodong Ma , Jia Liu , Guang Yang , Zifeng Yang , Xingxu Huang , Ming Liu
Products/Services Used Details Operation
SARS-CoV-2 qRT-PCR Detection Assay To validate the CRISPR/Cas12a-NER diagnostic accuracy, a total of 31 clinically extracted RNA samples were used for COVID-19 detection with the CRISPR/Cas12a-NER assay and TaqMan qPCR (GenScript, Nanjing, China) for the E gene in parallel.  Get A Quote

摘要

关键词